| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to the promotion of off-label uses of certain drugs, |
|
|
biological products, and devices. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Subtitle A, Title 6, Health and Safety Code, is |
|
|
amended by adding Chapter 444 to read as follows: |
|
|
CHAPTER 444. OFF-LABEL USE OF CERTAIN DRUGS, BIOLOGICAL PRODUCTS, |
|
|
AND DEVICES |
|
|
Sec. 444.001. DEFINITIONS. In this chapter: |
|
|
(1) "Health care provider" means a person other than a |
|
|
physician who is licensed, certified, or otherwise authorized by |
|
|
the laws of this state to dispense or prescribe a prescription drug |
|
|
in the ordinary course of business or practice of a profession. |
|
|
(2) "Off-label use" means the use of a drug, |
|
|
biological product, or device approved for use by the United States |
|
|
Food and Drug Administration in a manner other than the use for |
|
|
which it is approved by the United States Food and Drug |
|
|
Administration. |
|
|
(3) "Physician" means a person licensed to practice |
|
|
medicine in this state. |
|
|
Sec. 444.002. PROMOTION OF OFF-LABEL USE OF CERTAIN DRUGS, |
|
|
BIOLOGICAL PRODUCTS, OR DEVICES. (a) Notwithstanding other law, a |
|
|
pharmaceutical manufacturer or a representative of a |
|
|
pharmaceutical manufacturer may promote, in the manufacturer's |
|
|
advertising or marketing materials or directly to a physician or |
|
|
health care provider, a medically truthful and accurate off-label |
|
|
use of a drug, biological product, or device. |
|
|
(b) A physician or health care provider may communicate or |
|
|
otherwise promote to a patient an off-label use of a drug, |
|
|
biological product, or device consistent with the off-label use |
|
|
promoted for that drug, product, or device, as applicable, by a |
|
|
pharmaceutical manufacturer under Subsection (a). |
|
|
Sec. 444.003. DISCIPLINARY ACTION PROHIBITED FOR PROMOTION |
|
|
OF OFF-LABEL USE. (a) A pharmaceutical manufacturer or a |
|
|
representative of a pharmaceutical manufacturer may not be |
|
|
prosecuted or be subject to disciplinary action, including a |
|
|
revocation of or refusal to renew a license or certification, for |
|
|
promoting an off-label use of a drug, biological product, or device |
|
|
under Section 444.002. |
|
|
(b) The state regulatory authority of a physician or health |
|
|
care provider may not revoke or refuse to renew the license or |
|
|
certificate of or otherwise impose a disciplinary action against a |
|
|
physician or health care provider who communicates or otherwise |
|
|
promotes an off-label use of a drug, biological product, or device |
|
|
under Section 444.002. |
|
|
Sec. 444.004. HEALTH BENEFIT PLAN COVERAGE FOR OFF-LABEL |
|
|
USE NOT REQUIRED. This chapter does not require a health benefit |
|
|
plan to provide health benefit coverage for an off-label use of a |
|
|
drug, biological product, or device. |
|
|
Sec. 444.005. USE OF STATE MONEY FOR CERTAIN PURPOSES |
|
|
PROHIBITED. This state or a local governmental entity may not use |
|
|
public money to enforce or to cooperate with the federal government |
|
|
in enforcing 21 U.S.C. Sections 331 and 335 against a |
|
|
pharmaceutical manufacturer or a representative of a |
|
|
pharmaceutical manufacturer for promoting an off-label use under |
|
|
Section 444.002. |
|
|
SECTION 2. Section 444.003, Health and Safety Code, as |
|
|
added by this Act, applies to a prosecution or disciplinary action |
|
|
initiated or pending on or after the effective date of this Act. |
|
|
SECTION 3. This Act takes effect September 1, 2021. |